Skip to main content
SCORED: Sotagliflozin shows robust MACE benefit
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
SCORED: Sotagliflozin shows robust MACE benefit
User login
Username
Password
Reset your password
Concept
Lead
score
Cardiovascular Risk Management
1
1
Type 2 Diabetes Mellitus
0
0.96
SGLT2 Inhibitor
0
0.83
Heart Failure (HF)
0
0.44
Cerebrovascular Accident
0
0.38
Chronic Kidney Disease
0
0.33
Renal Failure
0
0.33
Heart
0
0.28
Hospital
0
0.28
Kidney
0
0.21
Receptors
0
0.21
Renal Disease
0
0.2
Cardiovascular disease
0
0.14
Patient History
0
0.14
Hemoglobin A1c
0
0.1
Food and Drug Administration (FDA)
0
0.07
Hemoglobin
0
0.07
Pandemic
0
0.07
COVID-19
0
0.06
Specialty
Lead
score
Cardiology
1
1
Diabetes & Endocrinology
0
1
Family Medicine/Primary Care
0
1
Internal Medicine
0
1
Emergency Medicine
0
0.84
Public Health & Prevention
0
0.76
Nephrology
0
0.66
Neurology & Neurosurgery
0
0.38
Critical Care
0
0.33
Pharmacist
0
0.33
Hospital Medicine
0
0.25
Pulmonary Medicine
0
0.21
Infectious Diseases
0
0.19
Edit Tags